For example, treatment with SIN has been shown to improve stress-induced heart failure by inhibiting the expression of collagen type I and III and increasing the ratio of interleukin-10 (IL-10)/IL-17 (Fu et al., 2020). This evidence concerns the gene IL10 and heart failure.